Cidara Therapeutics Skyrockets as Morgan Stanley Elevates Rating to 'Overweight'

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

A Pivotal Moment: HHS Advances Major Drug Pricing Rule for Review

Pharma's Big Win: How a Judge's Ruling Ignited Big Pharma Stocks

Trump's Bold Play: Delaying Pharma Tariffs for Deeper Drug Price Deals

Transatlantic Tremors: How US Drug Pricing Reforms Are Reshaping the Global Pharmaceutical Landscape

Trump's Bold Vision: Pushing for Direct Drug Deals to Slash Costs

AnaptysBio Unleashes Dual Powerhouse: Splitting into Dedicated Immunology and Oncology Ventures

Historic Shift: White House Reviews Landmark Drug Price Negotiation Rule

GSK Advances Endometrial Cancer Treatment Protocols, Seeking Leucovorin Label Update for Jemperli

GSK Responds to FDA Request: Leucovorin Label Update Confirms No Intent to Market for Autism Spectrum Disorder

Senator Warren Sounds Alarm: Measles Surge Threatens, RFK Jr.'s CDC Panel Under Fire for Vaccine Delays

West Coast States Forged Their Own Path: A Deep Dive into Independent Vaccine Guidance

CDC Launches Major Contract Study to Re-Examine Vaccines and Autism Link

GSK and India: Forging a Path to Affordable Vaccines for Neglected Diseases

Sanofi Stock Plunges as Zantac Lawsuit Risks Re-Emerge Following Key Judicial Ruling

Florida's Landmark Stand: Embracing Medical Freedom and Erasing Vaccine Mandates Across the Board

Wave Life Sciences Shares Tumble: What's Behind the Market's Disappointment?

GSK Revolutionizes Oncology in India with Landmark Launches of Jemperli and Zejula

GSK sells off partial stake in Haleon for $1.2B

GSK to sell 3.2% stake in spinoff Haleon: report